DSS BioHealth converts Series A Preferred into 60.5M common shares of Impact BioMedical

IMPACT BIOMEDICAL INC.

DSS BioHealth Security converted its Series A Convertible Preferred Stock into 60,496,041 shares of common stock.
Conversion was elected under Section 6 of the Certificate of Designation, effective after 75-day holding period.
The converted shares represent a significant increase in diluted share count, potentially impacting existing shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.